Jim Beiermann, Danny Irland of Southwestern Health Resources Talk ACO, Next Generation Programs (Pt. 1)

July 10, 2020

Jim Beiermann and Danny Irland, both of Southwestern Health Resources, discuss their focus of value-based care through ACO and Next Generation Programs.

Lisa Griffin of Jefferson Health Talks Race and Inequity (Pt. 3)

July 10, 2020

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

Biosimilars for Cancer an 'Emerging Success' Says NCCN's Koh

July 09, 2020

Vote in May made FDA-approved biosimilars an "appropriate substitution" for brand-name biologics in NCCN guidelines.

Lisa Griffin of Jefferson Health Talks Seamless Access, Payment and Insurance (Pt. 2)

July 09, 2020

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

Jack Linehan of Epstein Becker Green Discusses Drug Coupons, Accumulators

July 09, 2020

In this week's episode of Tuning Into The C-Suite podcast, Senior Editor Peter Wehrwein has a conversation with John "Jack" Linehan, a lawyer for Epstein Becker Green, about coupons and accumulators. Jack is an expert on drug distribution and reimbursement, and few people know as much about coupons and accumulators as he does. Peter and Jack go over some of the basics, who is advantaged and disadvantaged, and then dive into some the details on CMS regulations and how recent proposed changes to Medicaid best price rules would, if finalized, affect coupons and accumulators.

Excerpts From Our Interview with Lisa Griffin of Jefferson Health

July 09, 2020

Excerpts from our interview of Lisa Griffin, senior vice president of front-end operation, at Jefferson Health,

FDA Approves Hulio, the Sixth Biosimilar to Humira

July 08, 2020

Along with the other Humira biosimilars, Hulio will not be on the market till 2023.

Lisa Griffin of Jefferson Health Talks Telehealth, COVID-19 (Pt. 1)

July 08, 2020

Peter Wehrwein, senior editor at Managed Healthcare Executive, spoke with Lisa Griffin, senior vice president of front-end operations at Jefferson Health in Philadelphia, about the pivot to telehealth, "seamless access" and racism.

Gravie Introduces First-Of-Its-Kind Zero-Copay,-Deductible Employer-Sponsored Health Plan

July 08, 2020

The new plan, called Gravie Comfort, offers 100% coverage on most common healthcare services, including preventive care, primary care, specialist visits, labs and imaging, generic prescriptions, online care, and more – all at a cost comparable to most traditional group health plans.

New USPSTF Lung Cancer Screening Recommendations Would Double Scans Among Blacks, Women

July 08, 2020

Lowering the age and smoking history standards would result in substantially more Blacks and women being eligible for screening.

x